IRIS
COLUCCIA, Mauro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.916
AS - Asia 3.032
EU - Europa 2.523
SA - Sud America 785
AF - Africa 145
OC - Oceania 4
AN - Antartide 1
Totale 13.406
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.828
SG - Singapore 1.171
RU - Federazione Russa 923
CN - Cina 866
BR - Brasile 619
SE - Svezia 398
HK - Hong Kong 334
IT - Italia 234
DE - Germania 221
UA - Ucraina 209
VN - Vietnam 180
FI - Finlandia 170
FR - Francia 136
IN - India 105
GB - Regno Unito 98
CI - Costa d'Avorio 80
BD - Bangladesh 67
AR - Argentina 61
ID - Indonesia 46
CA - Canada 40
IQ - Iraq 36
TR - Turchia 31
CO - Colombia 29
MX - Messico 28
PK - Pakistan 25
EC - Ecuador 24
JP - Giappone 24
SA - Arabia Saudita 24
ZA - Sudafrica 23
PH - Filippine 20
VE - Venezuela 20
BE - Belgio 18
UZ - Uzbekistan 18
ES - Italia 17
IE - Irlanda 17
JO - Giordania 13
PL - Polonia 13
AT - Austria 12
CZ - Repubblica Ceca 12
IR - Iran 12
NL - Olanda 10
TN - Tunisia 10
CL - Cile 9
PE - Perù 8
BO - Bolivia 7
IL - Israele 7
KE - Kenya 7
AZ - Azerbaigian 6
EG - Egitto 6
LT - Lituania 6
PY - Paraguay 6
SN - Senegal 6
DO - Repubblica Dominicana 5
DZ - Algeria 5
LB - Libano 5
NP - Nepal 5
OM - Oman 5
AL - Albania 4
JM - Giamaica 4
KZ - Kazakistan 4
MA - Marocco 4
PT - Portogallo 4
RO - Romania 4
AU - Australia 3
GE - Georgia 3
MY - Malesia 3
PS - Palestinian Territory 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
BH - Bahrain 2
BN - Brunei Darussalam 2
CH - Svizzera 2
CR - Costa Rica 2
GR - Grecia 2
HN - Honduras 2
HR - Croazia 2
KG - Kirghizistan 2
KR - Corea 2
NI - Nicaragua 2
PA - Panama 2
QA - Qatar 2
RS - Serbia 2
SI - Slovenia 2
SV - El Salvador 2
TH - Thailandia 2
UY - Uruguay 2
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BY - Bielorussia 1
DM - Dominica 1
ET - Etiopia 1
HU - Ungheria 1
KH - Cambogia 1
KW - Kuwait 1
LK - Sri Lanka 1
MD - Moldavia 1
ME - Montenegro 1
MN - Mongolia 1
MU - Mauritius 1
Totale 13.403
Salva come PNG Salva come JPEG
Città #
Fairfield 634
Chandler 602
Ashburn 578
Woodbridge 577
Singapore 571
Jacksonville 461
Houston 371
San Jose 371
Hong Kong 332
Nyköping 327
Seattle 269
Ann Arbor 255
Cambridge 244
Beijing 213
Wilmington 213
Nanjing 141
Bari 133
New York 130
Lawrence 128
Roxbury 128
Lauterbourg 110
Boardman 89
Des Moines 84
Abidjan 80
Los Angeles 80
Dallas 75
Ho Chi Minh City 72
Helsinki 66
Princeton 57
Inglewood 55
São Paulo 47
Santa Clara 43
Brooklyn 42
Nanchang 42
Buffalo 41
Hebei 39
Council Bluffs 35
Shenyang 33
Jiaxing 32
San Diego 32
Dearborn 29
Hanoi 29
Munich 25
Pune 24
Tokyo 24
Guangzhou 20
San Francisco 19
Tianjin 19
Moscow 18
Baghdad 17
Belo Horizonte 17
Brussels 17
Dublin 17
Jakarta 17
Shanghai 17
Rio de Janeiro 16
Tashkent 16
Changsha 14
The Dalles 14
Toronto 14
Amman 13
Boston 13
Columbus 13
Frankfurt am Main 13
Ardabil 12
Brasília 12
London 12
Orem 12
Brno 11
Chicago 11
Falkenstein 11
Medellín 11
Montreal 11
Mumbai 11
Phoenix 11
Salvador 11
Auburn Hills 10
Chennai 10
Dong Ket 10
Johannesburg 10
Kunming 10
Leawood 10
Washington 10
Atlanta 9
Dhaka 9
Jinan 9
Ningbo 9
Quito 9
Riyadh 9
Rome 9
Santo André 9
Warsaw 9
Wuhan 9
Jeddah 8
Ribeirão Preto 8
San Mateo 8
Wuxi 8
Zhengzhou 8
Augusta 7
Buenos Aires 7
Totale 8.617
Salva come PNG Salva come JPEG
Nome #
Platinum complexes with cyclic ligands mimicking iminoether species, synthesis and biological activity 715
Cyclooxygenase-1 (COX-1) and COX-1 Inhibitors in Cancer: A Review of Oncology and Medicinal Chemistry Literature 216
Growth hormone secretagogues prevent dysregulation of skeletal muscle calcium homeostasis in a rat model of cisplatin-induced cachexia 197
Effect of mofezolac-galactose distance in conjugates targeting cyclooxygenase (COX)-1 and CNS GLUT-1 carrier 182
Cell Cycle Regulation by Ca2+-Activated K+ (BK) Channels Modulators in SH-SY5Y Neuroblastoma Cells 179
Improving knowledge on the activation of bone marrow fibroblasts in MGUS and MM disease through the automatic extraction of genes via a nonnegative matrix factorization approach on gene expression profiles. 177
Investigating Structural Requirements for the Antiproliferative Activity of Biphenyl Nicotinamides 175
The Challenge of Establishing Reliable Screening Tests for Selecting Anticancer Metal Compounds 170
Novel targeting of phospho-cMET overcomes drug resistance and induces antitumor activity in multiple myeloma 170
Effect of cisplatin containing liposomes formulated by unsaturated chain-containing lipids on gynecological tumor cells. 163
Effect of chirality in platinum drugs 160
Antimetastatic properties and DNA interactions of the novel class of dimeric Ru(III) compounds [Na]2{trans-RuCl4(Me2SO)]2(µ-L)} (L = ditopic, non-chelating aromatic N-ligand) 157
Mutagenic activity of some platinum complexes: chemical properties and biological activity 153
Intelligent microarray data analysis through non-negative matrix factorization to study human multiple myeloma cell lines 149
Antitumor trans-platinum DNA adducts: NMR and HPLC study of the interaction between a trans-Pt(iminoether) complex and the deoxy decamer d(CCTCGCTCTC).d(GAGAGCGAGG) 146
Biologic activity of platiunum complexes with proflavine 140
Endothelial cells in the bone marrow of patients with multiple myeloma 136
Mutagenic activity of some platinum complexes with monodentate and bidentate amines 132
Anti-leukaemic action of RuCl2 (DMSO)4 isomers and prevention of brain involvement on P388 leukaemia and on P388/DDP subline 127
Sterically hindered complexes of platinum(II) with planar heterocyclic nitrogen donors. A novel complex with 1-methyl-cytosine has a spectrum of activity different from cisplatin and is able of overcoming acquired cisplatin resistance 124
Antitumour platinum iminoether complexes 122
Platinum(II) based anticancer agents with a trans geometry 122
Biological activity of platinum complexes containing chiral centers on the nitrogen or carbon atoms of a chelate ring. 121
A preclinical overview on gold(III) compounds in the forefront of the targeted anticancer therapy. 121
Processo di sintesi di complessi di platino con imminoeteri e loro utilizzazione come agenti antitumorali e agenti modificanti le basi nucleotidiche 121
Antitumour ruthenium(II)-dimethylsulfoxide complexes 121
ANTIBACTERIAL AND ANTICANCER ACTIVITY OF PLATINUM COMPLEXES WITH CHIRAL DIAMINES 118
Bone marrow fibroblasts provide a permissive microenvironement for multiple myeloma cells 117
Efficacy of 5FU combined to Na[trans-RuCl4(DMSO)Im], a novel selective antimetastatic agent, on the survival time of mice with P388 leukemia, P388/DDP subline, and MCa mammary carcinoma 117
Ruthenium-sulfoxide complexes with a specific antimetastatic activity 115
DNA binding specificity of the antitumor complexes cis- and trans-RuCl2(DMSO)4 determined by primer extension footprinting assay 115
Trans-Platinum Compounds in Cancer Therapy: A largely Unexplored Strategy for Identifying Novel Antitumor Platinum Drugs 113
Antitumor trans iminoether platinum di- and oligonucleotide adducts studied by NMR. 113
Treatment with cyclosporin A does not affect macrophage procoagulant activity and plasminogen activator inhibitor in mice 113
Antitumour platinum-iminoether complexes 112
Biological Activity of Platinum Complexes Containing Chiral Centers on the Nitrogen or Carbon atoms of a Chelate Diamine Ring. Inorg. Chim. Acta, 112
Antitumour platinum iminoether complexes 112
Platinum(II)-Acyclovir complexes of acyclovir: synthesis, antiviral and antitumor activity 112
Antitumour activity and matrix metalloproteinase inhibition by platinum-diethyl{(methylsulfinyl)methyl}phosphonate complexes 111
Bone marrow fibroblasts provide a permissive microenvironment for multiple myeloma cells. 111
Antitumor active trans-platinum compounds 110
Antitumor activity of trans platinum complexes 108
Synthesis and in vitro antitumor activity of platinum acetonimine complexes 107
CITOTOSSICITA' IN VITRO DI ALCUNI MATERIALI DENTALI 106
Effect of isomerism at non-leaving ligands in platinum anticancer drugs 106
A Framework for Biological Data Normalization, Interoperability, and Mining for Cancer Microenvironment Analysis 104
null 104
Mutagenic activity of transition metal complexes: relation structure-mutagenic and antibacterial activity for some Pd(II), Pt(II) and Rh(I) complexes 103
Mutagenic activity of transition metal complexes: relation structure-mutagenic and antibacterial activity for some Pd(II), Pt(II) and Rh(I) complexes 101
Gain-of-Function STIM1 L96V Mutation Causes Myogenesis Alteration in Muscle Cells From a Patient Affected by Tubular Aggregate Myopathy 101
Salivary up-regulation of human polymorphonuclear leucocyte chemotaxis and adhesion-molecule expression 100
Anttitumor activity of trans-platinum species 100
Breast Cancer's Microarray Data: Pattern Discovery Using Nonnegative Matrix Factorizations. 99
Pharmacological action of the platinum-iminoether complex cis-[PtCl2{E-HN=C(OMe)}NH3] 98
Trans-Platinum Complexes in Cancer Therapy 98
In vitro cisplatin effects on phagocyte functions 98
Antiviral and antitumour properties of a platinum(II) complex with acyclovir 98
Bone Marrow Fibroblasts and Multiple Myeloma Progression 95
Analisi dell’espressione genica (Dna Microarray) in cellule endoteliali e cellule tumorali dopo trattamento con il farmaco antimetastatico sperimentale Nami-A 95
Current Status of trans-Platinum Compounds in Cancer Therapy 95
Comparison of cytotoxicity, cellular accumulation and cell cycle modifications of cisplatin and trans-[PtCl2E(iminoether)2] in human and ovarian carcinoma cell lines 94
null 92
Cellular and biochemical properties of antitumour trans platinum-iminoether complexes 92
A trans-platinum complex showing higher antitumor activity than the cis congeners 92
Salivary up-regulation of PMN chemotaxis and adhesion molecules expression 91
Leading-edge gold(III) derivatives in targeted anticancer therapy: in vivo acute toxicity investigation and transcriptomic analysis of treatment-induced response in two human breast cancer cell lines. 91
Complessi antitumorali di platino a geometria trans 90
Cytotoxicity and DNA binding mode of new platinum iminoether derivatives with different configuration at the iminoether ligands 90
null 88
Iminoethers as Carrier Ligands: A Novel trans-Platinum Complex Possessing in Vitro and in Vivo Antitumour Activity 88
Effect of antitumor platinum compounds with trans geometry on the induction of cytotoxicity and cell cycle modifications 86
Bone Marrow Fibroblasts and Multiple Myeloma Progression. 86
DIFFERENT BINDING TO DNA OF ENANTIOMERIC PLATINUM COMPLEXES ASSESSED BY INHIBITION OF RESTRICTION ENZYME-ACTIVITY 84
Ulteriori contributi allo studio dell'interazione cisplatino-DNA 83
Inibizione di metalloproteasi da parte di complessi di platino con analoghi bisfosfonati 83
Interaction of RuCl2 (dimethylsulphoxide)4 isomers with DNA 82
Water soluble ruthenium(III)-dimethylsulfoxide complexes: chemical behavior and pharmacological properties 82
Platinum complexes with bisphosphonate analogue: a novel dual mechanism of antitumour action 80
Na[trans-RuCl4(DMSO)Im]2DMSO: antimetastatic ruthenium 79
Inhibition of endothelial cell function and angiogenesis by the metastasis inhibitor NAMI-A 78
Identification of genes associated with platinum iminoether compounds activity in ovarian cancer cells 77
Mechanistic studies on platinum(II) complexes with iminoethers: a trans platinum antitumor agent. 77
MMP activity inhibition by platinum-diethyl[(methylsulfinyl)methyl]phosphonate (SMP) complexes” 76
Response of MCa mammary carcinoma to cisplatin and to Na(trans- Rucl4(DMSO)Im): Selective inhibition of spontaneous lung metastases by the ruthenium complex. 75
Complessi di platino a geometria trans: nuove strategie di scoperta e sviluppo di farmaci antitumorali di platino. 75
Effects of trans-[PtCl2(NH3){Z-HN=C(OMe)Me}] (trans-Z) and Transplatin on cell-cycle progression and gene expression of SVOK-3 ovarian cancer cells 74
A new generation of platinum anticancer complexes with trans geometry 74
Complessi antitumorali di platino a geometria trans 74
Screening tests for selecting anticancer metal compounds 73
In vitro effects of ruthenium complex [ImH][trans-RuCl4(DMSO)Im] on angiogenenic propreties of endothelial cells 72
Method for synthesizing complexes of platinum with iminoethers and their use as antitumoral drugs and nucleotide base modifiers 71
The IS-BioBank project: a framework for biological data normalization, interoperability, and mining for cancer microenvironment analysis 71
The development of tumor-inhibiting ruthenium dimethylsulfoxide complexes 70
The Bisphosphonate Zoledronic Acid Affects the Angiogenic Phenotype of Bone Marrow Endothelial Cells in Multiple Myeloma Patients 70
Iminoethers as carrier ligands: a novel trans-platinum complex possessing in vitro and in vivo antitumor activity 70
null 68
DNA interaction properties of platinum –iminoether complexes 68
DNA adducts of antitumor trans-[PtCl2(E-imimo ether)2] 67
Mutagenic activity of some paltinum complexes: Chemical properties and biological activity 67
null 67
Totale 11.280
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.730
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.730
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202155 0 0 0 0 0 0 0 0 0 0 0 55
2021/2022787 21 121 1 30 32 33 32 35 44 49 156 233
2022/20231.524 217 144 123 145 196 202 6 194 233 11 22 31
2023/2024565 40 87 25 27 69 183 4 35 12 10 1 72
2024/20251.919 138 30 183 64 46 132 206 137 54 94 294 541
2025/20264.394 564 172 335 486 490 229 434 105 1.105 350 111 13
Totale 13.715